The role of pharmaceutical companies in the opioid epidemic has been reported widely and analyzed in minute detail. We know the basic story: Research for lifesaving medicines morphs into deep, institutionalized greed. There’s more to it than that story line, and a recent piece in The New York Times Book Review sums up some of the best work on the subject done to date. Check out the Dec. 17 “Prescribed Reading” column by Abigail Zuger for a compact summary of five books that belong on any shelf dedicated to understanding the opioid crisis.
More News
Harm reduction, and a tale of two cities
This well-written and carefully reported article in The Nation looks at the dramatically different responses to opioid epidemic in Philadelphia and Vancouver, BC. The quotes from the determined activists who work behind these efforts are …
Portland Business Journal notes CODA Research study
“In Oregon, marijuana is second only to alcohol when it comes to admissions for substance abuse treatment, yet it’s hard to find any targeted programs here or elsewhere,” reports Portland Business Journal writer Elizabeth Hayes. …
2/26/2014